Concepedia
Statistics
Publications
15
Citations
434
H-Index
12
Active since
1984
Affiliations
Klinikum Konstanz(Current)
University of Konstanz
MS-Schramberg (Germany)
Max Planck Institute of Biophysics
Max Planck Society
R. Boer is an author at Klinikum Konstanz specializing in pharmacology, medicine, and pharmacotherapy.
Top concepts
MedicinePharmacologyPharmacotherapyPhysiologyMolecular PharmacologyBiochemistryDrug DiscoveryDrug ResistanceNeuropharmacologyCell Biology
Publications per year
1984–2022
Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance
Volker Gekeler, R. Boer, Florian Überall et al. · British Journal of Cancer · 1996 · 119 citations · Full text
Drug Target, Biochemistry, G Protein-coupled Receptor +6
The Specific Bisindolylmaleimide PKC-Inhibitor GF 109203X Efficiently Modulates MRP-Associated Multiple Drug Resistance
Volker Gekeler, R. Boer, W Ise et al. · Biochemical and Biophysical Research Communications · 1995 · 64 citations
Medicinal Chemistry, Drug Target, Biochemistry +9
The affinity, selectivity and biological activity of telenzepine enantiomers
Christian Schudt, R. Boer, Manfrid Eltze et al. · European Journal of Pharmacology · 1989 · 34 citations
Functional Selectivity, Medicine, Neuropharmacology +5
Reversible Labeling of a Chemosensitizer Binding Domain of p-Glycoprotein with a Novel 1,4-Dihydropyridine Drug Transport Inhibitor<sup>,</sup>
R. Boer, Manfred Dichtl, Christoph H. Borchers et al. · Biochemistry · 1996 · 31 citations
Photoaffinity labeling of the V1 vasopressin receptor in plasma membranes from rat liver.
R. Boer, Falk Fahrenholz · Journal of Biological Chemistry · 1985 · 27 citations · Full text
V1 Vasopressin Receptor, Experimental Pharmacology, Reactive Vasopressin Analogues +17
1–5 of 15